Healthcare >> Analyst Interviews >> September 14, 2001

Large Cap Biotechnology Stocks: Ronald Renaud – Bear, Stearns & Co

RONALD C. RENAUD joined the Bear, Stearns Healthcare/Biotechnology team in May 2001 as an Associate Director. Previously, he was a Senior Biotechnology Analyst at JP Morgan Chase covering companies in the life science technology sector. Prior to joining JP Morgan Chase in May 2000, he was an Associate Analyst on the Healthcare/Biotechnology team at Bear, Stearns. From 1994 to 1999, Mr. Renaud worked at Amgen in clinical research and development as well as finance. From 1990 to 1994, Ron worked at the Dana-Farber Cancer Institute with roles in both clinical and basic research. He holds a BA from Saint Anselm College and an MBA from the Marshall School of Business at the University of Southern California. Profile
TWST: What is your coverage area with the Bear healthcare team?

Mr. Renaud: As a senior biotechnology analyst, I share coverage of the

large cap biotech space with Akhtar Samad. My coverage